Pharmaceutical Drug Targets and Diseases
From Proteopedia
(Difference between revisions)
| Line 109: | Line 109: | ||
***[[Matt Routh sandbox|MDM2 Bound to p53]] | ***[[Matt Routh sandbox|MDM2 Bound to p53]] | ||
***[[P-glycoprotein:_Why_Cancer_Drugs_Fail|P-Glycoprotein: Why Cancer Drugs Fail]] | ***[[P-glycoprotein:_Why_Cancer_Drugs_Fail|P-Glycoprotein: Why Cancer Drugs Fail]] | ||
| - | ***[[ | + | *** Oncogenes |
| + | ****[[C-Myc]] - Proto-Oncogenic Gene | ||
| + | ****[[P53]] - Tumor Suppressing Gene | ||
| + | ****[[SRC]] - Proto-Oncogenic Tyrosine Kinase Gene | ||
***[[Ann_Taylor_sandbox_Proteins_in_Cancer|Proteins in Cancer]] | ***[[Ann_Taylor_sandbox_Proteins_in_Cancer|Proteins in Cancer]] | ||
***[[Chad Sorenson sandbox 1|Retinoblastoma Protein]] | ***[[Chad Sorenson sandbox 1|Retinoblastoma Protein]] | ||
Revision as of 11:23, 27 September 2010
The following is a list of major pharmaceutical compound targets, drugs, and information organized by disease.
Proteopedia Page Contributors and Editors (what is this?)
David Canner, Alexander Berchansky, Eran Hodis, Thomas J. Stout, Wayne Decatur
